| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $81.30M | $119.52M | $114.87M | $112.72M | $118.78M |
| SG&A | $41.50M | $49.73M | $49.66M | $50.67M | $54.84M |
| Operating Income | -$122.80M | -$169.26M | -$164.53M | -$163.39M | -$173.62M |
| Interest Expense | – | – | $30.84M | $22.70M | $19.67M |
| Tax Expense | $2.01M | $2.31M | $0.00 | $0.00 | $0.00 |
| Net Income | -$3.35M | -$156.81M | -$117.81M | $47.42M | $194.24M |
| EPS (basic) | -0.0500 | -2.7000 | -1.8800 | 0.7600 | 3.1200 |
| EPS (diluted) | -0.0500 | -2.7000 | -1.8800 | 0.7600 | 3.1200 |
| Shares (diluted) | – | – | – | $62.74M | $62.34M |